Skip to main content
Clinical Trials/NCT06457087
NCT06457087
Not yet recruiting
Not Applicable

Confocal Laser Endomicroscopy in the Diagnosis of Peripheral Pulmonary Lesions

Shanghai Chest Hospital1 site in 1 country150 target enrollmentJune 2024

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Peripheral Pulmonary Lesions
Sponsor
Shanghai Chest Hospital
Enrollment
150
Locations
1
Primary Endpoint
Diagnostic accuracy of CLE in differential diagnosis of benign and malignant PPLs
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

The purpose of the study is to describe confocal laser endomicroscopy (CLE) interpretation criteria for different types of peripheral pulmonary lesions (PPLs), with histopathological correlation, and to perform the validation of these criteria.

Detailed Description

CLE is a modern imaging technique that uses an excitation laser light to create real-time microscopic images of tissues. During transbronchial lung biopsy, CLE has the potential to provide real-time non-invasive diagnosis of PPLs ("optical biopsy"). In this study, we will obtain CLE images within the target lesion before taking a biopsy during transbronchial lung biopsy of PPLs. We will compare the results of the "optical biopsy" with the corresponding histopathological results and develop CLE interpretation criteria for different types of PPLs. In addition, we will perform the validation of these criteria to evaluate the ability of CLE to discriminate between benign and malignant PPLs.

Registry
clinicaltrials.gov
Start Date
June 2024
End Date
June 2025
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Jiayuan Sun

Director, Department of Respiratory Endoscopy

Shanghai Chest Hospital

Eligibility Criteria

Inclusion Criteria

  • Patients older than 18 years.
  • Chest CT shows peripheral pulmonary lesions (peripheral pulmonary lesions are lesions beyond the segmental bronchi that are invisible during bronchoscopy), and transbronchial biopsy is considered necessary and feasible.
  • Patients who have good compliance and sign informed consent.

Exclusion Criteria

  • Patients with known allergy for fluorescein.
  • Pregnant or lactating women.
  • Patients with contraindications of bronchoscopy.
  • The investigators believe that patient has other conditions that are not suitable for the study.

Outcomes

Primary Outcomes

Diagnostic accuracy of CLE in differential diagnosis of benign and malignant PPLs

Time Frame: 6 months post-procedure

Diagnostic accuracy is defined as the number of lesions correctly identified as malignant or benign using our proposed CLE interpretation criteria divided by the total number of lesions.

Secondary Outcomes

  • Incidence of complications(1 month post-procedure)
  • Sensitivity, specificity of CLE in differential diagnosis of benign and malignant PPLs(6 months post-procedure)
  • positive predictive value, and negative predictive value of CLE in differential diagnosis of benign and malignant PPLs(6 months post-procedure)
  • Diagnostic accuracy of CLE in differential diagnosis of different types of PPLs(6 months post-procedure)

Study Sites (1)

Loading locations...

Similar Trials